Catherine is a senior editor at The Scientist.
View full profile.
Learn about our editorial policies.
ABOVE: adapted from: © istock.com, saemilee; © istock.com, ttsz; © istock.com, Dmitry Kovalchuk
Neurodegenerative diseases have long been associated with aggregations of apparently toxic proteins, whether that’s amyloid precursor protein (APP) in Alzheimer’s disease, α-synuclein in Parkinson’s, or huntingtin in Huntington’s. But when not mutated, misfolded, or otherwise misbehaving, these proteins seem to play critical roles in brain development and function, leading some researchers to suspect that the loss of those normal functions may play a role in disease. Some of the purported functions of three of these proteins, assessed primarily through in vitro and animal studies, are shown below.
Amyloid-β, which is made when amyloid precursor protein (APP) breaks down, forms plaques in the brains of people with Alzheimer’s disease, and has long been viewed by researchers and pharmaceutical companies as the cause of neurodegeneration. But scientists are now digging into the the regular physiological roles of APP (a selection of which are highlighted below), and identifying ways in which the peptide may be important for normal brain function.
Alpha-synuclein misfolds and forms aggregations in the brains of people with Parkinson’s disease and related neurodegenerative disorders. While the protein has been better studied than some peptides involved in neurodegeneration, researchers are still discovering new physiological functions for it (a selection of which are highlighted below), some of which may be important in understanding its role in disease.
The causative mutation of Huntington’s, in the huntingtin gene, was identified in 1993. Much work since has focused on how the resulting mutant protein, which aggregates inside neurons and invades cell nuclei, contributing to the pathology of the disease. However, researchers are focusing more and more on the roles of the regular protein in healthy brain function (several of which are highlighted below) and on how better understanding these roles might shine a light on how the disease develops.
Read the full story.
This article was featured in August 2022, Issue 1 of the digest
Understanding the normal roles of peptides associated with neurodegneration
Already a Member?
© 1986–2022 The Scientist. All rights reserved.